LOCAL CEREBRAL BLOOD-FLOW FOLLOWING THE INTRASTRIATAL ADMINISTRATION OF VASOACTIVE-INTESTINAL-PEPTIDE OR PEPTIDE HISTIDINE ISOLEUCINE IN THE RAT

被引:7
|
作者
TUOR, UI
EDVINSSON, L
KELLY, PAT
MCCULLOCH, J
机构
[1] UNIV EDINBURGH,WESTERN GEN HOSP,DEPT CLIN NEUROSCI,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND
[2] UNIV LUND HOSP,DEPT INTERNAL MED,S-22185 LUND,SWEDEN
[3] UNIV GLASGOW,WELLCOME SURG INST,GLASGOW G12 8QQ,SCOTLAND
基金
英国惠康基金;
关键词
Caudate nucleus; Cerebral circulation; Cerebral glucose utilization; Peptide histidine isoleucine; Vasoactive intestinal peptide;
D O I
10.1016/0167-0115(90)90023-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of the intrastriatal microinjection of either vasoactive intestinal peptide (VIP) or a related peptide - peptide histidine isoleucine (PHI) - on local cerebral blood flow in the striatum was examined using iodo[14C]antipyrine quantitative autoradiography. In 37 rats, an injection needle was inserted into a chronically implanted guide cannula and 1 μl of vehicle, VIP or PHI was injected into the striatum. Blood flow in sham controls was reduced by 15% in proximity to the injection site, when compared with blood flow in the contralateral unijected control side (P < 0.01). Similarly, following PHI administration (20 pmol), blood flow in the striatum was reduced by 14% when compared to that contralaterally (P < 0.02). In contrast, following VIP administration (20 pmol), blood flow in proximity to the injection site was increased compared to flow in the contralateral striatum in 4 8 animals with the mean flow being elevated by 10% (n.s.) compared to blood flow contralaterally. VIP and PHI had similar effects on local cerebral glucose utilization in the caudate nucleus, their response being equivalent to that of sham animals. These experiments suggest that VIP and PHI have a differential influence on the microvasculature of the caudate nucleus, with VIP but not PHI mediating cerebrovascular dilation. © 1990.
引用
收藏
页码:255 / 264
页数:10
相关论文
共 50 条
  • [21] LIGHT SELECTIVELY ALTERS VASOACTIVE INTESTINAL PEPTIDE AND PEPTIDE HISTIDINE ISOLEUCINE IMMUNOREACTIVITY WITHIN THE RAT SUPRACHIASMATIC NUCLEUS
    ALBERS, HE
    MINAMITANI, N
    STOPA, E
    FERRIS, CF
    BRAIN RESEARCH, 1987, 437 (01) : 189 - 192
  • [22] COEXISTENCE OF VASOACTIVE-INTESTINAL-PEPTIDE (VIP)-LIKE, PEPTIDE HISTIDINE ISOLEUCINE AMIDE (PHI)-LIKE, AND GASTRIN RELEASING PEPTIDE (GRP)-LIKE IMMUNOREACTIVITY IN NEURONS OF THE RAT SUPRACHIASMATIC NUCLEUS
    OKAMURA, H
    MURAKAMI, S
    UDA, K
    SUGANO, T
    TAKAHASHI, Y
    YANAIHARA, C
    YANAIHARA, N
    IBATA, Y
    BIOMEDICAL RESEARCH-TOKYO, 1986, 7 (04): : 295 - 299
  • [23] COMMONALITIES IN VASOACTIVE-INTESTINAL-PEPTIDE AND PEPTIDE N-TERMINAL HISTIDINE C-TERMINAL ISOLEUCINE STIMULATION OF N-ACETYLTRANSFERASE ACTIVITY IN THE RAT PINEAL
    YUWILER, A
    BRAMMER, GL
    BENNETT, BL
    JOURNAL OF PINEAL RESEARCH, 1993, 15 (02) : 81 - 87
  • [24] MOLECULAR CHARACTERISTICS AND PEPTIDE SPECIFICITY OF VASOACTIVE-INTESTINAL-PEPTIDE RECEPTORS FROM RAT CEREBRAL-CORTEX
    COUVINEAU, A
    GAMMELTOFT, S
    LABURTHE, M
    JOURNAL OF NEUROCHEMISTRY, 1986, 47 (05) : 1469 - 1475
  • [25] PEPTIDE HISTIDINE ISOLEUCINE AND VASOACTIVE INTESTINAL PEPTIDE STIMULATE PROLACTIN SECRETION FROM CULTURED RAT PITUITARY-CELLS
    BJORO, T
    HAUG, E
    OSTBERG, BC
    TORJESEN, PA
    GAUTVIK, KM
    ACTA ENDOCRINOLOGICA, 1985, 109 : 127 - 127
  • [26] LOCALIZATION OF VASOACTIVE INTESTINAL PEPTIDE AND PEPTIDE HISTIDINE ISOLEUCINE IMMUNOREACTIVITY AND MESSENGER-RNA WITHIN THE RAT SUPRACHIASMATIC NUCLEUS
    STOPA, EG
    MINAMITANI, N
    JONASSEN, JA
    KING, JC
    WOLFE, H
    MOBTAKER, H
    ALBERS, HE
    MOLECULAR BRAIN RESEARCH, 1988, 4 (04): : 319 - 325
  • [27] IS VASOACTIVE-INTESTINAL-PEPTIDE (VIP) SIGNIFICANTLY NATRIURETIC IN THE RAT
    LONERGAN, MA
    FIELD, MJ
    KIDNEY INTERNATIONAL, 1991, 40 (03) : 571 - 571
  • [28] GLYCOGENOLYTIC EFFECT OF VASOACTIVE-INTESTINAL-PEPTIDE IN THE RAT INVIVO
    SANCHEZ, V
    GOBERNA, R
    CALVO, JR
    EXPERIENTIA, 1991, 47 (06): : 625 - 626
  • [29] CHOLECYSTOKININ, VASOACTIVE-INTESTINAL-PEPTIDE AND PEPTIDE HISTIDINE METHIONINE RESPONSES TO FEEDING IN ANOREXIA-NERVOSA
    HARTY, RF
    PEARSON, PH
    SOLOMON, TE
    MCGUIGAN, JE
    REGULATORY PEPTIDES, 1991, 36 (01) : 141 - 150
  • [30] VASOACTIVE-INTESTINAL-PEPTIDE IMMUNOREACTIVITY IN ALZHEIMER CEREBRAL-CORTEX
    MAZUREK, MF
    BEAL, MF
    MALLOY, JR
    MARTIN, JB
    ANNALS OF NEUROLOGY, 1986, 20 (01) : 126 - 126